US Capitol Capsule: FDA pleads with drug makers for early warning on shortages
This article was originally published in Scrip
Executive Summary
As the US FDA continues to confront the increasing challenge of shortages of medications, most notably, oncology products, anaesthetics and antibiotics, the agency is pleading with drug makers to notify regulators as early as possible of any production problems or other issues affecting the supply of medicines or their active ingredients.